SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, single-arm pilot study will examine usability and preliminary effects of SugarVita 2.0 in adults with type 2 diabetes. Participants will use the digital game over 12 weeks, following a predefined schedule, while researchers assess diabetes self-management, self-confidence, distress, knowledge, HbA1c, and, when available, continuous glucose monitoring metrics. The game provides a semi-personalized glucose simulator and interactive decision-making about nutrition, activity, and medications. Prior work with the original SugarVita suggested improvements in knowledge and self-management, and SugarVita 2.0 aims to enhance education and personalization. Usability and engagement metrics, including play time and frequency, will be collected to understand how users interact with the game.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 years or older
* Diagnosis of type 2 diabetes mellitus (T2DM)
* Written informed consent obtained before any study procedures
* HbA1c \>55 mmol/mol prior to study participation
* For participants with T2DM only: BMI \>25 kg/m²
* Sufficient command of the Dutch language to complete study questionnaires

Exclusion Criteria:

* Pregnancy or breastfeeding
* Active malignancy, except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin

Where it's running

• Maxima Medical Centre
  Eindhoven, North Brabant, Netherlands Recruiting

Study contacts

• Principal investigator: Pleun Wouters - van Poppel, MSc — Maxima Medical Center
• Study coordinator: Dr. Pleun Wouters-van Poppel, PhD
• Email: pleun.van.poppel@mmc.nl
• Phone: +31 (0)40 888 6300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• What personal, social, and access factors affect taking diabetes medicines

  This project will see if patients' knowledge, beliefs, family support, healthcare communication, and access problems influence how adults with diabetes take their medicines.

  Recruiting University of Malaya · Ambāla, Haryana · NCT07420634

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

• iLet Bionic Pancreas started through primary care for adults on insulin

  This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.

  Recruiting University of Colorado, Denver · Aurora, Colorado and 1 other locations · NCT07011147

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Health coaching program for adults with type 2 diabetes

  This study is testing if a health coaching program can help adults with type 2 diabetes manage their condition better and improve their overall health compared to standard care.

  Recruiting National Healthcare Group Polyclinics · Singapore and 2 other locations · NCT06444074

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.